The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia.

acute lymphoblastic leukemia vinblastine vincristine

Journal

Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624

Informations de publication

Date de publication:
09 Aug 2024
Historique:
revised: 18 07 2024
received: 15 05 2024
accepted: 23 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: aheadofprint

Résumé

An attractive flower from the island of Madagascar has in part saved the lives of thousands of children with acute lymphoblastic leukemia (ALL). Random mutations and alterations to the genome led to the evolution of genes encoding enzymes, which would provide the periwinkle flower an arsenal of secondary metabolites to survive within the Madagascar ecosystem. Of the over 200 alkaloid compounds synthesized by the periwinkle, vincristine and vinblastine are the two most well-known being used for chemotherapy treatments, including for children with ALL. The complexities of the multi-step biosynthesis of vincristine and vinblastine, which has taken years to decode, highlight the importance of protecting the vast biodiversity on earth as other natural products that can save lives await to be discovered. This review addresses the discovery of vincristine and vinblastine, as well as the history of their existence, in nature.

Identifiants

pubmed: 39120434
doi: 10.1002/pbc.31247
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e31247

Subventions

Organisme : Ring Screw Textron Endowed Chair
Organisme : Children's Hospital of Michigan Foundation
Organisme : Litvak Foundation/Elana Fund

Informations de copyright

© 2024 The Author(s). Pediatric Blood & Cancer published by Wiley Periodicals LLC.

Références

Rowinsky EK. Vinca alkaloids and epipodophyllotoxins. In: Perry MC, ed. The Chemotherapy Source Book. Williams & Wilkins; 1992.
Noble RL, Beer CT, Cutts JH. Role of chance observations in chemotherapy: Vinca rosea. Ann N Y Acad Sci. 1958;76(3):882‐894. doi:10.1111/j.1749‐6632.1958.tb54906.x
Duffin J. Poisoning the spindle: serendipity and discovery of the anti‐tumor properties of the Vinca alkaloids. Pharm Hist. 2002;44(2):64‐76.
Duffin J. Poisoning the spindle: serendipity and discovery of the anti‐tumor properties of the Vinca alkaloids (Part II). Pharm Hist. 2002;44(3):105‐119.
Kreig M. Green Medicine; the Search for Plants That Heal. Rand McNally; 1964:462.
Johnson IS, Armstrong JG, Gorman M. The Vinca alkaloids: a new class of oncolytic agents. Cancer Res. 1963;23:1390‐13427.
Johnson IS. Drugs from Third World plants. Science. 1992;257(5072):860. doi:10.1126/science.1489402
Zhang J, Hansen LG, Gudich O, et al. A microbial supply chain for production of the anti‐cancer drug vinblastine. Nature. 2022;609(7926):341‐347. doi:10.1038/s41586‐022‐05157‐3
Frei E 3rd, Franzino A, Shnider BI, et al. Clinical studies of vinblastine. Cancer Chemother Rep. 1961;12:125‐129.
Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemias. Cancer Res. 1963;23:613‐621.
Lowenbraun S, DeVita VT, Serpick AA. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease. Blood. 1970;36(6):704‐717.
Evans AE, Farber S, Brunet S, Mariano PJ. Vincristine in the treatment of acute leukemia in children. Cancer. 1963;16:1302‐1306. doi:10.1002/1097‐0142(196310)16
Karon M, Freireich EJ. The role of vincristine in the treatment of childhood acute leukemia. Clin Pharmacol Ther. 1966;7(3):332‐339. doi:10.1002/cpt196673332
Hardisty RM, McElwain TJ, Darby CW. Vincristine and prednisone for the induction of remissions in acute childhood leukaemia. Br Med J. 1969;2(5658):662‐665. doi:10.1136/bmj.2.5658.662
Simone JV, Aur RJ, Hustu HO, Verzosa M, Pinkel D. Combined modality therapy of acute lymphocytic leukemia. Cancer. 1975;35(1):25‐35. doi:10.1002/1097‐0142(197501)35
Christian D. Macquarie University BHI. Big History. 1st American ed. Dorling Kindersley Publishing Inc.; 2016.
Banfalvi G. Prebiotic pathway from ribose to RNA formation. Int J Mol Sci. 2021;22(8):3857. doi:10.3390/ijms22083857
Enchev V, Slavova S. Self‐catalytic mechanism of prebiotic reactions: from formamide to pterins and guanine. Phys Chem Chem Phys. 2021;23(34):19043‐19053. doi:10.1039/d1cp02158c
Roy D, Najafian K, von Rague Schleyer P. Chemical evolution: the mechanism of the formation of adenine under prebiotic conditions. Proc Natl Acad Sci U S A. 2007;104(44):17272‐17277. doi:10.1073/pnas.0708434104
Biscans A. Exploring the emergence of RNA nucleosides and nucleotides on the early Earth. Life (Basel). 2018;8(4):57. doi:10.3390/life8040057
Koga T, Naraoka H. A new family of extraterrestrial amino acids in the Murchison meteorite. Sci Rep. 2017;7(1):636. doi:10.1038/s41598‐017‐00693‐9
Oba Y, Takano Y, Furukawa Y, et al. Identifying the wide diversity of extraterrestrial purine and pyrimidine nucleobases in carbonaceous meteorites. Nat Commun. 2022;13(1):2008. doi:10.1038/s41467‐022‐29612‐x
Naraoka H, Takano Y, Dworkin JP, et al. Soluble organic molecules in samples of the carbonaceous asteroid (162173) Ryugu. Science. 2023;379(6634):eabn9033. doi:10.1126/science.abn9033
Yabuta H, Cody GD, Engrand C, et al. Macromolecular organic matter in samples of the asteroid (162173) Ryugu. Science. 2023;379(6634):eabn9057. doi:10.1126/science.abn9057
Oba Y, Koga T, Takano Y, et al. Uracil in the carbonaceous asteroid (162173) Ryugu. Nat Commun. 2023;14(1):1292. doi:10.1038/s41467‐023‐36904‐3
Moskowitz C. Asteroid delivery. Sci Am. 2023;329:34‐39.
Miller SL, Urey HC. Organic compound synthesis on the primitive earth. Science. 1959;130(3370):245‐251. doi:10.1126/science.130.3370.245
Johnson AP, Cleaves HJ, Dworkin JP, Glavin DP, Lazcano A, Bada JL. The Miller volcanic spark discharge experiment. Science. 2008;322(5900):404. doi:10.1126/science.1161527
Doig AJ. Frozen, but no accident—why the 20 standard amino acids were selected. FEBS J. 2017;284(9):1296‐1305. doi:10.1111/febs.13982
Pressman A, Blanco C, Chen IA. The RNA world as a model system to study the origin of life. Curr Biol. 2015;25(19):R953‐R963. doi:10.1016/j.cub.2015.06.016
Higgs PG, Lehman N. The RNA world: molecular cooperation at the origins of life. Nat Rev Genet. 2015;16(1):7‐17. doi:10.1038/nrg3841
Mizuuchi R, Furubayashi T, Ichihashi N. Evolutionary transition from a single RNA replicator to a multiple replicator network. Nat Commun. 2022;13(1):1460. doi:10.1038/s41467‐022‐29113‐x
Joyce GF, Szostak JW. Protocells and RNA self‐replication. Cold Spring Harb Perspect Biol. 2018;10(9):a034801. doi:10.1101/cshperspect.a034801
Damer B, Deamer D. The Hot Spring hypothesis for an origin of life. Astrobiology. 2020;20(4):429‐452. doi:10.1089/ast.2019.2045
Weiss MC, Preiner M, Xavier JC, Zimorski V, Martin WF. The last universal common ancestor between ancient Earth chemistry and the onset of genetics. PLoS Genet. 2018;14(8):e1007518. doi:10.1371/journal.pgen.1007518
Reeves CV. The development of the East African margin during Jurassic and Lower Cretaceous times: a perspective from global tectonics. Pet Geosci. 2018;24:41‐56.
Callmander MW, Phillipson PB, Schatz GE, et al. The endemic and non‐endemic vascular flora of Madagascar. Plant Ecol Evol. 2011;144:121‐125.
Caputi L, Franke J, Farrow SC, et al. Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle. Science. 2018;360(6394):1235‐1239. doi:10.1126/science.aat4100
Qu Y, Safonova O, De Luca V. Completion of the canonical pathway for assembly of anticancer drugs vincristine/vinblastine in Catharanthus roseus. Plant J. 2019;97(2):257‐266. doi:10.1111/tpj.14111
Zhou P, Chen M. Exploration of the mechanisms of differential indole alkaloid biosynthesis in dedifferentiated and cambial meristematic cells of Catharanthus roseus using transcriptome sequencing. Front Genet. 2022;13:867064. doi:10.3389/fgene.2022.867064
Kellner F, Kim J, Clavijo BJ, et al. Genome‐guided investigation of plant natural product biosynthesis. Plant J. 2015;82(4):680‐692. doi:10.1111/tpj.12827
Das A, Sarkar S, Bhattacharyya S, Gantait S. Biotechnological advancements in Catharanthus roseus (L.) G. Don. Appl Microbiol Biotechnol. 2020;104(11):4811‐4835. doi:10.1007/s00253‐020‐10592‐1
Kumar S, Singh B, Singh R. Catharanthus roseus (L.) G. Don: a review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities. J Ethnopharmacol. 2022;284:114647. doi:10.1016/j.jep.2021.114647
Isah T. Stress and defense responses in plant secondary metabolites production. Biol Res. 2019;52(1):39. doi:10.1186/s40659‐019‐0246‐3
Roepke J, Salim V, Wu M, et al. Vinca drug components accumulate exclusively in leaf exudates of Madagascar periwinkle. Proc Natl Acad Sci U S A. 2010;107(34):15287‐15292. doi:10.1073/pnas.0911451107
Duge de Bernonville T, Carqueijeiro I, Lanoue A, et al. Folivory elicits a strong defense reaction in Catharanthus roseus: metabolomic and transcriptomic analyses reveal distinct local and systemic responses. Sci Rep. 2017;7:40453. doi:10.1038/srep40453
Meisner J, Weissenberg M, Palevitch D, Aharonson N. Phagodeterrency induced by leaves and leaf extracts of Catharanthus roseus in the larva of Spodoptera littoralis. J Econ Entomol. 1981;74:131‐135.
Hanafy MS, Matter MA, Asker MS, Rady MR. Production of indole alkaloids in hairy root cultures of Catharanthus roseus L. and their antimicrobial activity. S Afr J Bot. 2016;105:9‐18.
Ramezani A, Haddad R, Sedaghati B, Jafari D. Effects of fungal extracts on vinblastine and vincristine production and their biosynthesis pathway genes in Catharanthus roseus. S Afr J Bot. 2018;119:163‐171.
Grellier P, Sinou V, Garreau‐de Loubresse N, Bylen E, Boulard Y, Schrevel J. Selective and reversible effects of Vinca alkaloids on Trypanosoma cruzi epimastigote forms: blockage of cytokinesis without inhibition of the organelle duplication. Cell Motil Cytoskeleton. 1999;42(1):36‐47. doi:10.1002/(SICI)1097‐0169(1999)42
Liu Y, Patra B, Singh SK, et al. Terpenoid indole alkaloid biosynthesis in Catharanthus roseus: effects and prospects of environmental factors in metabolic engineering. Biotechnol Lett. 2021;43(11):2085‐2103. doi:10.1007/s10529‐021‐03179‐x
She J, Yan H, Yang J, Xu W, Su Z. croFGD: Catharanthus roseus functional genomics database. Front Genet. 2019;10:238. doi:10.3389/fgene.2019.00238
Li C, Wood JC, Vu AH, et al. Single‐cell multi‐omics in the medicinal plant Catharanthus roseus. Nat Chem Biol. 2023;19(8):1031‐1041. doi:10.1038/s41589‐023‐01327‐0
Blount ZD, Borland CZ, Lenski RE. Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proc Natl Acad Sci U S A. 2008;105(23):7899‐7906. doi:10.1073/pnas.0803151105
Blount ZD, Maddamsetti R, Grant NA, et al. Genomic and phenotypic evolution of Escherichia coli in a novel citrate‐only resource environment. eLife. 2020;9:e55414. doi:10.7554/eLife.55414
Moger‐Reischer RZ, Glass JI, Wise KS, et al. Evolution of a minimal cell. Nature. 2023;620(7972):122‐127. doi:10.1038/s41586‐023‐06288‐x
Pichersky E, Gang DR. Genetics and biochemistry of secondary metabolites in plants: an evolutionary perspective. Trends Plant Sci. 2000;5(10):439‐445. doi:10.1016/s1360‐1385(00)01741‐6

Auteurs

Jeffrey W Taub (JW)

Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA.
Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.
Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.

Steven A Buck (SA)

Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA.

Ana C Xavier (AC)

Division of Hematology/Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Holly Edwards (H)

Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.

Larry H Matherly (LH)

Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.

Yubin Ge (Y)

Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.

Classifications MeSH